Cargando…

Real-world assessment of the impact of “OFF” episodes on health-related quality of life among patients with Parkinson’s disease in the United States

BACKGROUND: Many patients with Parkinson’s disease (PD) who receive carbidopa/levodopa experience symptom reemergence or worsening, or “OFF” episodes. This study assessed the association of “OFF” episodes with health-related quality of life (HRQoL). METHODS: US-specific data from the 2017 and 2019 A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thach, Andrew, Jones, Eddie, Pappert, Eric, Pike, James, Wright, Jack, Gillespie, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846980/ https://www.ncbi.nlm.nih.gov/pubmed/33516182 http://dx.doi.org/10.1186/s12883-021-02074-2

Ejemplares similares

Patient Preferences for Treating “OFF” Episodes in Parkinson’s Disease: A Discrete Choice Experiment
por: Thach, Andrew, et al.
Publicado: (2021)

Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson’s Disease
por: Thach, Andrew, et al.
Publicado: (2021)

Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson’s Disease: Is the Prophylactic Use of an Antiemetic Necessary?
por: Hauser, Robert A., et al.
Publicado: (2023)

Impact of Dementia-Related Behavioral Symptoms on Healthcare Resource Use and Caregiver Burden: Real-World Data from Europe and the United States
por: Chekani, Farid, et al.
Publicado: (2021)

Feasibility of home dose optimization of apomorphine sublingual film in Parkinson’s disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study
por: Kassubek, Jan, et al.
Publicado: (2023)

Evaluation of morning bradykinesia in Parkinson’s disease in a United States cohort using continuous objective monitoring
por: Isaacson, S.H., et al.
Publicado: (2022)

Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System
por: Jones, Eddie, et al.
Publicado: (2021)

The Impact of Agitation in Dementia on Caregivers: A Real-World Survey
por: Schein, Jeff, et al.
Publicado: (2022)

Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?
por: Isaacson, Stuart H., et al.
Publicado: (2022)

Associations Between Relapses and Psychosocial Outcomes in Patients With Schizophrenia in Real-World Settings in the United States
por: Lin, Dee, et al.
Publicado: (2021)

Impact of advanced Parkinson’s disease on caregivers: an international real-world study
por: Martinez-Martin, Pablo, et al.
Publicado: (2023)

Istradefylline to Treat Patients with Parkinson’s Disease Experiencing “Off” Episodes: A Comprehensive Review
por: Berger, Amnon A., et al.
Publicado: (2020)

Istradefylline for OFF Episodes in Parkinson’s Disease: A US Perspective of Common Clinical Scenarios
por: Isaacson, Stuart H, et al.
Publicado: (2022)

Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel
por: Isaacson, Stuart H., et al.
Publicado: (2023)

Real‐world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real‐world study
por: Gladstone, Jonathan, et al.
Publicado: (2021)

Real-World Treatment Patterns in Patients with Vitiligo in the United States
por: Rosmarin, David, et al.
Publicado: (2023)

Istradefylline Versus Opicapone for “Off” Episodes in Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Singh, Alok, et al.
Publicado: (2021)

Effective Management of “OFF” Episodes in Parkinson’s Disease: Emerging Treatment Strategies and Unmet Clinical Needs
por: Masood, Nbaa, et al.
Publicado: (2023)

Comparison of Laboratory and Daily-Life Gait Speed Assessment during ON and OFF States in Parkinson’s Disease
por: Corrà, Marta Francisca, et al.
Publicado: (2021)

Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
por: Alsaadi, Taoufik, et al.
Publicado: (2022)

1782. Real-World HIV Diagnostic Testing Patterns in the United States
por: Karichu, James, et al.
Publicado: (2019)

Correction to: Real-World Treatment Patterns in Patients with Vitiligo in the United States
por: Rosmarin, David, et al.
Publicado: (2023)

Use of real-world evidence in economic assessments of pharmaceuticals in the United States
por: Lee, Woojung, et al.
Publicado: (2021)

Istradefylline: A novel agent in the treatment of “off” episodes associated with levodopa/carbidopa use in Parkinson disease
por: Cummins, Lauren, et al.
Publicado: (2022)

An Individualized Multi-Modal Approach for Detection of Medication “Off” Episodes in Parkinson’s Disease via Wearable Sensors
por: Arasteh, Emad, et al.
Publicado: (2023)

RWON Study: The Real-World Walled-off Necrosis Study
por: Pawar, Ankush, et al.
Publicado: (2021)

Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States
por: Soliman, Ahmed M., et al.
Publicado: (2018)

Real-world Duration of Use and Dosing Frequency of Daratumumab in Patients With Multiple Myeloma in the United States
por: Fonseca, Rafael, et al.
Publicado: (2023)

Aripiprazole in the treatment of acute episode of schizophrenia: a real-world study in China
por: Li, Qian, et al.
Publicado: (2023)

Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States
por: McAllister, Peter, et al.
Publicado: (2021)

Real-world renal function among patients with multiple myeloma in the United States
por: Mikhael, Joseph, et al.
Publicado: (2021)

Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States
por: Hunnicutt, Jacob N., et al.
Publicado: (2023)

Inventory of real world data sources in Parkinson’s disease
por: Tanguy, Audrey, et al.
Publicado: (2017)

Software life cycle management standards: real-world solutions and scenarios for savings
por: Wright, David
Publicado: (2011)

Treatment Goals in Schizophrenia: A Real-World Survey of Patients, Psychiatrists, and Caregivers in the United States, with an Analysis of Current Treatment (Long-Acting Injectable vs Oral Antipsychotics) and Goal Selection
por: Fitzgerald, Heather M, et al.
Publicado: (2021)

Cost of managing an episode of relapse in multiple sclerosis in the United States
por: O'Brien, Judith A, et al.
Publicado: (2003)

Real-world clinical predictors of manic/hypomanic episodes among outpatients with bipolar disorder
por: Tokumitsu, Keita, et al.
Publicado: (2021)

Real-World Effectiveness of Chemotherapy in Elderly Patients With Metastatic Bladder Cancer in the United States
por: Galsky, Matthew D., et al.
Publicado: (2018)

Real-world implementation of video-observed therapy in an urban TB program in the United States
por: Perry, A., et al.
Publicado: (2021)

Real-World Analysis of Thromboembolic Events and Mortality of COVID-19 Outpatients in the United States
por: Peacock, W. Frank, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j0uodt419tsu69o5fnad18cl1f